CDC- BRFSS – ACBS 18-20 Child Prevalence Table 7

Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among children1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2018-2020.
State/Territory Current
Sample
size±
% SE§ 95% CI
California 68 38.3 7.6 (23.4 – 53.2)
Connecticut 149 32.1 5.9 (20.5 – 43.7)
Florida 133 24.2 6.2 (12.0 – 36.4)
Hawaii 66 N/A N/A (N/A – N/A)
Indiana 94 33.9 6.4 (21.4 – 46.4)
Kansas 107 30.8 5.2 (20.6 – 41.0)
Michigan 183 25.9 3.9 (18.3 – 33.5)
Minnesota 165 22.9 4.9 (13.3 – 32.5)
Missouri 87 29.3 7.2 (15.2 – 43.4)
Montana 59 N/A N/A (N/A – N/A)
Nebraska 127 27.3 5.9 (15.7 – 38.9)
New Hampshire 67 29.7 7.2 (15.6 – 43.8)
New Mexico 73 N/A N/A (N/A – N/A)
New York 68 N/A N/A (N/A – N/A)
Ohio 124 23.5 6.9 (10.0 – 37.0)
Oregon 56 N/A N/A (N/A – N/A)
Pennsylvania 70 36.2 7.4 (21.7 – 50.7)
Rhode Island 52 39.5 9.0 (21.9 – 57.1)
Texas 121 33.1 9.2 (15.1 – 51.1)
Utah 188 19.5 3.3 (13.0 – 26.0)
Vermont 108 47.7 6.2 (35.5 – 59.9)
Wisconsin 68 N/A N/A (N/A – N/A)
Puerto Rico 114 11.4 3.2 (5.1 – 17.7)
24 States / Area 2,448 31.1 2.5 (26.2 – 36.0)
Median 29.5
Range 11.4-47.7

1 Aged < 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf